Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm Su

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Annals of Hematology|February 28, 2026
Emicizumab in the treatment of acquired hemophilia A: A Two-Center experienceMalcolm Su, Sean Yates, Melissa Sanchez, et al.
Expert Opinion on Emerging Drugs|April 25, 2024
Emerging drugs for the treatment of atopic dermatitis: a focus on phase 2 and phase 3 trialsOgechi Obed, Albert C Chong, Malcolm Su, et al.
Cardio-Oncology (London, England)|August 22, 2025
Cardiac function surveillance practices and outcomes in patients with HER2-positive breast cancer treated with trastuzumab: a retrospective cohort study across a safety-net and tertiary care settingLe Huang, Pratyusha Manthena, Malcolm Su, et al.
Clinical Reviews in Allergy & Immunology|July 20, 2024
Fungal Head and Neck Dermatitis: Current Understanding and ManagementAlbert C Chong, Francisco José Navarro-Triviño, Malcolm Su, et al.
Clinical Breast Cancer|August 15, 2025
Clinical and Pathological Features of Early-Stage Metaplastic Carcinoma and Associated Patient OutcomesMalcolm Su, Stevie Saxon-Filipe, Chul Ahn, et al.
British Journal of Haematology|February 24, 2026
Resumption of bone-modifying agents in relapsed multiple myeloma does not improve outcomes: A real-world analysisMalcolm Su, Adeel M Khan, Andrew J Cowan, et al.
American Journal of Preventive Medicine|August 2, 2025
Patterns of Breast Cancer Screening and Access to Care in a Safety-Net SystemMalcolm Su, Shifa Kanjwal, Madeleine Hopson, et al.
The Journal of Surgical Research|June 8, 2021
Longitudinal Risk Management for Patients with Increased Risk for Breast CancerMalcolm Su, Victoria Huynh, Michael Bronsert, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Annals of Hematology|February 28, 2026
Emicizumab in the treatment of acquired hemophilia A: A Two-Center experienceMalcolm Su, Sean Yates, Melissa Sanchez, et al.
Expert Opinion on Emerging Drugs|April 25, 2024
Emerging drugs for the treatment of atopic dermatitis: a focus on phase 2 and phase 3 trialsOgechi Obed, Albert C Chong, Malcolm Su, et al.
Cardio-Oncology (London, England)|August 22, 2025
Cardiac function surveillance practices and outcomes in patients with HER2-positive breast cancer treated with trastuzumab: a retrospective cohort study across a safety-net and tertiary care settingLe Huang, Pratyusha Manthena, Malcolm Su, et al.
Clinical Reviews in Allergy & Immunology|July 20, 2024
Fungal Head and Neck Dermatitis: Current Understanding and ManagementAlbert C Chong, Francisco José Navarro-Triviño, Malcolm Su, et al.
Clinical Breast Cancer|August 15, 2025
Clinical and Pathological Features of Early-Stage Metaplastic Carcinoma and Associated Patient OutcomesMalcolm Su, Stevie Saxon-Filipe, Chul Ahn, et al.
British Journal of Haematology|February 24, 2026
Resumption of bone-modifying agents in relapsed multiple myeloma does not improve outcomes: A real-world analysisMalcolm Su, Adeel M Khan, Andrew J Cowan, et al.
American Journal of Preventive Medicine|August 2, 2025
Patterns of Breast Cancer Screening and Access to Care in a Safety-Net SystemMalcolm Su, Shifa Kanjwal, Madeleine Hopson, et al.
The Journal of Surgical Research|June 8, 2021
Longitudinal Risk Management for Patients with Increased Risk for Breast CancerMalcolm Su, Victoria Huynh, Michael Bronsert, et al.
Pageof 1